Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[DNA vaccination].

D Moradpour1, H E Blum

  • 1Abteilung Innere Medizin II, Medizinische Universitätsklinik Freiburg. moradpou@ruf.uni-freiburg.de

Praxis
|December 5, 2000
PubMed
Summary
This summary is machine-generated.

DNA vaccination uses plasmid DNA to trigger immune responses against diseases. This promising approach, particularly for generating cytotoxic T cells, is advancing to human trials for conditions like tuberculosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of hepatitis B virus on steatosis in hepatitis C virus co-infected subjects: A multi-centre study and systematic review.

Journal of viral hepatitis·2018
Same author

Trends in hepatitis C-related mortality in Switzerland.

Journal of viral hepatitis·2017
Same author

Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person-centred approach.

Journal of viral hepatitis·2016
Same author

[Hepatitis C: 25 years of progress with still major challenges].

Revue medicale suisse·2015
Same author

The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice.

Cell death and differentiation·2015
Same author

Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding.

Alimentary pharmacology & therapeutics·2015
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Vaccinology

Context:

  • DNA vaccination leverages the in vivo transfection of cells like muscle and dendritic cells by plasmid DNA.
  • Expression plasmids can be administered via intramuscular, intraepidermal, or oral routes.

Purpose:

  • To induce robust humoral and cellular immune responses against specific encoded proteins.
  • To explore the potential of DNA vaccination in generating cytotoxic T cells for therapeutic applications.

Summary:

  • DNA vaccination has demonstrated efficacy in preclinical animal models against viral, bacterial, parasitic, and malignant diseases.
  • The strategy is particularly effective in inducing cytotoxic T cell responses, showing therapeutic promise.
  • Successful application in an animal model of tuberculosis highlights its potential.

Related Experiment Videos

Impact:

  • DNA vaccination is a developing strategy with potential applications in infectious and malignant diseases.
  • Early-phase human trials are underway, with results anticipated to guide future development.
  • This technology could offer new avenues for prophylactic and therapeutic immunization.